Back to search
🇺🇸

United States · US · US:64764-251_2346b7f5-b2c1-45f0-9f8f-5cbb4b202857

OSENI

Orange BookUNIISPLATC A10BH

Last synced from FDA National Drug Code directory (United States) on

Identification

ManufacturerTakeda Pharmaceuticals America, Inc.
CountryUS (United States)
ATC codeA10BH
Dispensing
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026

Packs · 3

  • ndc11
    6476425103
    30 TABLET, FILM COATED in 1 BOTTLE (64764-251-03)
  • ndc11
    6476425104
    90 TABLET, FILM COATED in 1 BOTTLE (64764-251-04)
  • ndc11
    6476425105
    500 TABLET, FILM COATED in 1 BOTTLE (64764-251-05)

Annotations

UNII (FDA Substance ID)
EEN99869SC
ALOGLIPTIN BENZOATE
RxCUI 1368000
Orange Book
N022426
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
  "unii": {
    "unii": "EEN99869SC",
    "rxcui": "1368000",
    "inchikey": "KEJICOXJTRHYAK-XFULWGLBSA-N",
    "display_name": "ALOGLIPTIN BENZOATE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "spl_meta": {
    "4c619ed9-fe3e-4158-9938-80c6c3493d55": {
      "match": "brand_token",
      "title": "OSENI (ALOGLIPTIN AND PIOGLITAZONE) TABLET, FILM COATED [TAKEDA PHARMACEUTICALS AMERICA, INC.]",
      "spl_version": "23",
      "published_date": "2025-03-24"
    }
  },
  "productid": "64764-251_2346b7f5-b2c1-45f0-9f8f-5cbb4b202857",
  "productndc": "64764-251",
  "dosage_form": "TABLET, FILM COATED",
  "orange_book": {
    "appl_no": "022426",
    "products": [
      {
        "rs": false,
        "rld": true,
        "te_code": null,
        "strength": "EQ 25MG BASE;EQ 15MG BASE",
        "product_no": "001",
        "approval_date": "Jan 25, 2013"
      },
      {
        "rs": false,
        "rld": true,
        "te_code": null,
        "strength": "EQ 25MG BASE;EQ 30MG BASE",
        "product_no": "002",
        "approval_date": "Jan 25, 2013"
      },
      {
        "rs": true,
        "rld": true,
        "te_code": null,
        "strength": "EQ 25MG BASE;EQ 45MG BASE",
        "product_no": "003",
        "approval_date": "Jan 25, 2013"
      },
      {
        "rs": false,
        "rld": true,
        "te_code": null,
        "strength": "EQ 12.5MG BASE;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",
        "product_no": "004",
        "approval_date": "Jan 25, 2013"
      },
      {
        "rs": false,
        "rld": true,
        "te_code": null,
        "strength": "EQ 12.5MG BASE;EQ 30MG BASE",
        "product_no": "005",
        "approval_date": "Jan 25, 2013"
      },
      {
        "rs": false,
        "rld": true,
        "te_code": null,
        "strength": "EQ 12.5MG BASE;EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",
        "product_no": "006",
        "approval_date": "Jan 25, 2013"
      }
    ],
    "appl_type": "N"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE",
  "proprietary_name": "OSENI",
  "active_ingred_unit": "mg/1; mg/1",
  "application_number": "NDA022426",
  "marketing_category": "NDA",
  "nonproprietary_name": "alogliptin and pioglitazone",
  "start_marketing_date": "20130125",
  "active_numerator_strength": "25; 15"
}

Related drugs

Other records sharing ATC code A10BH.

Access this data programmatically

Query OSENI and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.